$3.95 2%
ABSI Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Absci

Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster.

Price $3.95
Target Price Sign up
Volume 1,550,000
Market Cap $456M
Year Range $1.25 - $6.59
Dividend Yield 0%
Revenue per Employee $27,705
Earnings Date August 14 '24
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24900,0008.7M-7.8M-22M-20M-0.220
Q4 '23340,00010M-9.9M-24M-22M-0.250
Q3 '23740,00010M-9.6M-22M-21M-0.240
Q2 '233.4M32M-28M-42M-41M-0.450
Q1 '231.3M10M-9.1M-23M-22M-0.260

Insider Transactions View All

Jonasson Zachariah filed to sell 384,751 shares at $5.
June 14 '24
Phoenix Venture Partners II LP filed to sell 11,279,522 shares at $4.4.
May 28 '24
Redmile Group, LLC filed to buy 8,253,316 shares at $4.5.
March 5 '24
Phoenix Venture Partners II LP filed to sell 14,379,522 shares at $1.4.
February 14 '24
Phoenix Venture Partners II LP filed to sell 14,379,522 shares at $1.4.
February 14 '24

What is the Market Cap of Absci?

The Market Cap of Absci is $456M.

How Many People Work at Absci?

As of our latest update, Absci employed approximately 193 people worldwide. However, it's important to note that Absci's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Absci's revenue per employee?

$27,705. To calculate Absci's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

When does Absci report earnings?

Absci will report its next earnings on August 14 '24.

What is the current stock price of Absci?

Currently, the price of one share of Absci stock is $3.95.

How can I analyze the ABSI stock price chart for investment decisions?

The ABSI stock price chart above provides a comprehensive visual representation of Absci's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Absci shares. Our platform offers an up-to-date ABSI stock price chart, along with technical data analysis and alternative data insights.

Does ABSI offer dividends to its shareholders?

As of our latest update, Absci (ABSI) does not offer dividends to its shareholders. Investors interested in Absci should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Absci?

Some of the similar stocks of Absci are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.